Anzeige
Mehr »
Samstag, 07.02.2026 - Börsentäglich über 12.000 News
Kupfer im Fokus: Warum US-Projekte jetzt neu gelesen werden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
41 Leser
Artikel bewerten:
(0)

Treatments Commence Using UAE's First Varian TrueBeam' System

DUBAI, United Arab Emirates, Nov. 14, 2016 /PRNewswire/ -- Cancer patients in the United Arab Emirates have gained access to advanced radiotherapy and radiosurgery treatments with the clinical introduction of the country's first TrueBeam' medical linear accelerator from Varian Medical Systems (NYSE:VAR). A male patient with neck Hodgkin's lymphoma received the first treatment on a TrueBeam at Mediclinic City Hospital's new comprehensive cancer center in Dubai.

"This landmark treatment means that patients in the UAE now have access to one of the most precise and efficient technologies for treating cancer," said Dr. Salim Chaib Rassou, the cancer center's lead radiation oncologist. "We will be able to achieve high levels of precision, excellent image quality and fast throughput using the new TrueBeam technology."

"This is an important clinical advancement in the treatment of many different types of cancer in the UAE and brings new hope to cancer sufferers across the country," he added.

"Mediclinic City Hospital is very proud to be able to offer the first TrueBeam radiotherapy treatment in the UAE at our newly-opened comprehensive cancer center," said hospital director Christian Schuhmacher. "The center has been set up in collaboration with experts at Mediclinic's Swiss sister company Hirslanden, with TrueBeam data matched to that at Hirslanden. This means that it is possible for a patient to be treated both in Dubai, or if necessary at Hirslanden in Switzerland, without the need for dose recalculations."

Varian's TrueBeam system features a multitude of technical innovations that dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. It was designed to treat tumors in a fast and precise manner, including cancers such as lung and breast that move during treatment as the patient breathes in and out.

"The Varian team in Dubai is very excited to see the first TrueBeam system installed in the UAE providing patients with advanced clinical treatments," said Mutaz Mikashfi, Varian's service area manager, Middle East and North Africa. "This new system in Dubai expands our collaboration with the Mediclinic group beyond our established long-term support for Mediclinic Hirslanden in Switzerland. We are looking forward to working closely with Mediclinic City Hospital in Dubai to provide patients with the most modern radiotherapy and radiosurgery treatments."

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging. The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiation. The company provides comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is also a premier supplier of X-ray imaging components, including tubes, digital detectors, cables and connectors as well as image processing software and workstations for use in medical and industrial settings, as well as for security and non-destructive testing. Varian Medical Systems employs approximately 7,700 people who are located at manufacturing sites in North America, Europe, and China and sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.

Press Contact

Neil Madle
Varian Medical Systems
+44 7786 526068
neil.madle@varian.com

© 2016 PR Newswire
Vorsicht, geheim!
2026 startet mit einem Paukenschlag: Der DAX outperformt den US-Markt, Nachzügler holen auf. Ein erstes Signal, dass der Bullenmarkt an Breite gewinnt. Während viele Anleger weiter auf die großen Tech-Namen setzen, hat sich im Hintergrund längst ein Umschwung vollzogen. Der Fokus verschiebt sich weg von überteuerten KI-Highflyern hin zu soliden Qualitätswerten aus der zweiten Reihe.

Anleger, die jetzt clever agieren, setzen nicht auf das, was war, sondern auf das, was kommt. Unternehmen mit gesunder Bilanz, unterschätztem Potenzial und begrenztem Abwärtsrisiko könnten 2026 zu den großen Gewinnern zählen. Die Gefahr einer schärferen Korrektur bleibt real, gerade für passiv aufgestellte Investoren.

In unserem neuen Spezialreport stellen wir fünf Aktien vor, die genau jetzt das Potenzial für überdurchschnittliche Renditen bieten. Stark, günstig und bislang kaum im Fokus.

Jetzt kostenlosen Report herunterladen – bevor es andere tun!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.